Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA 5001, Australia.
J Clin Epidemiol. 2011 Feb;64(2):223-8. doi: 10.1016/j.jclinepi.2010.02.015. Epub 2010 Jun 17.
To compare the performance of Charlson index and Rx-Risk score using data from Australian Department of Veterans' Affairs.
A study of older adults (N=94,714) who had both Charlson and Rx-Risk scores based on their hospital diagnoses and prescription medication dispensings during the baseline year (January 2005-December 2005). Predictive ability of 1-year and 3-year mortality was compared by Akaike information criterion model fit statistic and c statistic in logistic regression models. We also compared the scores for identifying specific medical conditions.
Both indices were significant predictors of all-cause mortality (P<0.0001). Of the population identified with a condition from either score, Rx-Risk score identified more than 95% of patients with gastric, respiratory, or cardiovascular condition, compared with Charlson index only identifying 2%, 31%, and 14%, respectively. The indices were comparable regarding diabetes. The Charlson index identified 83% of patients with dementia and 67% of those with cancers, whereas Rx-Risk score identified 38% and 43%, respectively.
Both the Charlson and Rx-Risk scores predict mortality, but neither index identified all comorbidities. Based on data availability, preferences, and research purposes, investigators can use either Charlson index or Rx-Risk score to adjust for comorbidity.
利用澳大利亚退伍军人事务部的数据比较 Charlson 指数和 Rx-Risk 评分的性能。
一项对老年人(N=94714)的研究,他们在基线年(2005 年 1 月至 2005 年 12 月)根据他们的住院诊断和处方药物配药既有 Charlson 评分又有 Rx-Risk 评分。通过逻辑回归模型中的 Akaike 信息准则模型拟合统计量和 c 统计量比较了 1 年和 3 年死亡率的预测能力。我们还比较了识别特定医疗条件的评分。
两种指数都是全因死亡率的显著预测因子(P<0.0001)。在两种评分中,Rx-Risk 评分确定了超过 95%的患有胃、呼吸或心血管疾病的患者,而 Charlson 指数仅分别确定了 2%、31%和 14%的患者。对于糖尿病,两种指数相当。Charlson 指数确定了 83%的痴呆症患者和 67%的癌症患者,而 Rx-Risk 评分分别确定了 38%和 43%的患者。
Charlson 指数和 Rx-Risk 评分都可预测死亡率,但没有一种指数能识别所有合并症。根据数据可用性、偏好和研究目的,研究人员可以使用 Charlson 指数或 Rx-Risk 评分来调整合并症。